Picture of TriSalus Life Sciences logo

TLSI — TriSalus Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Brief: TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

March 27 (Reuters) - TriSalus Life Sciences Inc TLSI.O:

TRISALUS LIFE SCIENCES Q4 PRETAX PROFIT USD -10.109 MILLION

TRISALUS LIFE SCIENCES Q4 REVENUE USD 8.261 MILLION VERSUS. IBES ESTIMATE USD 8.12 MILLION

TRISALUS LIFE SCIENCES Q4 INCOME FROM OPERATIONS USD -7.58 MILLION

TRISALUS LIFE SCIENCES Q4 BASIC EPS USD -0.4 VERSUS. IBES ESTIMATE USD -0.32

TRISALUS LIFE SCIENCES Q4 GROSS PROFIT USD 7.045 MILLION

Source text: ID:nBw2n60nWa

Further company coverage: TLSI.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on TriSalus Life Sciences

See all news